151 -10 (60) 2023 — Ashuralieva N.D., Jo’raeva M.A. — PREVALENCE OF VIRAL LIVER CIRRHOSIS AMONG THE RURAL POPULATION

PREVALENCE OF VIRAL LIVER CIRRHAshuralieva N.D., Jo’raeva M.A., Mamasoliev N.S.OSIS AMONG THE RURAL POPULATION

Ashuralieva N.D., Andijan State Medical Institute of Uzbekistan

Jo’raeva M.A., Andijan State Medical Institute of Uzbekistan

Mamasoliev N.S. Andijan State Medical Institute of Uzbekistan

Resume

There are few studies of etiological, epidemiological, clinical and diagnostic characteristics of liver cirrhosis among the rural population of Andijan region, improvement of its preventive measures. According to a retrospective analysis, when analyzing the prevalence of disease in Markhamat district, the rate of morbidity, disability and death increased year by year. The fact that the recorded numbers are increasing and the disease is asymptomatic in many cases confirms that the problem of its study is extremely urgent. At the same time, in the 20-40 age group, death from cirrhosis of the liver exceeds that from ischemic heart disease.

Nowadays, regardless of the etiological factor, patients with liver cirrhosis die due to one or more complications. These are bleeding from varicose veins of the stomach and esophagus, hepatic encephalopathy, hepatocellular carcinoma and infection. Prediction of the mentioned complications, study of etiological factors based on regional conditions is considered an urgent problem of medicine

Key words: liver cirrhosis, hepatitis, portal hypertensive gastropathy, bleeding, atrophic gastritis

First page

872

Last page

877

For citation: Ashuralieva N.D., Jo’raeva M.A., Mamasoliev N.S. – PREVALENCE OF VIRAL LIVER CIRRHOSIS AMONG THE RURAL POPULATION //New Day in Medicine 2023 10(60): 872-877 https://newdaymedicine.com/index.php/2023/12/27/l-710/

LIST OF REFERENCES:

  1. Бабич С. М., Алейник В.А. Изменение желудочной секреции при введении в периферическую и портальную вены пентагастрина и лей-энкефалина // Врач-аспирант, – Воронеж, 2010;5,2(42):252-253.
  2. Коротько Г.Ф. Протеолиз в регуляции функций системы пищеварения // Экспериментальная и клиническая гастроэнтерология. 2013;10:24-26.
  3. Hoffmaster K.A, Zamek-Gliszczynski MJ, Pollack GM, Brouwer KL. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport system. // J. Pharmacol. Exp. Ther., 2004;311(3):1204-1208.
  4. Huynh D., Nguyen N. Q. Gastrointestinal Dysfunction in Chronic Liver Disease // J Gastrointest Dig Syst. 2015;5(257):1-3.
  5. Kumar A., Mishra S.R., Sharma P., Sharma B.C., Sarin S.K. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics. // J Clin Gastroenterol. 2010 Apr;44(4):294-300.
  6. Pan W.D., Xun R.Y., Chen Y.M. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors. Hepatobiliary Pancreat Dis Int. 2002 Nov;1(4):527-31.
  7. Sepanlou SG,Safiri S,Bisignano C et al./The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. // Lancet Gastroenterol Hepatol. 2020; 5:245-266.

file

download